Categories:
Navigate:
Search:
  ALS Researchers Create Epilepsy in Rats
Posted August 5, 2002 in ALS Research

Copyright 2002 U.P.I.
United Press International
August 5, 2002, Monday

Johns Hopkins University researchers have created a new rat model of epilepsy accidentally by attempting to block a chemical messenger in the brain associated with Lou Gehrig's disease. Epilepsy long has been tied to reduced levels of a brain chemical called GABA, which dampens nerve cells' likelihood of firing. But researchers were studying a messenger called glutamate, which never had been linked to epilepsy.

"We wanted to see how reducing transport of this messenger affected other brain chemicals and the brain itself, but we hadn't expected it to result in epilepsy," researchers said. "Now we need to track it down in people to see if the same mechanism is involved in the human condition."

Although glutamate transport problems may not contribute to human epilepsy, the finding may lead to new ways to treat it, the researchers said. For example, getting more glutamate into GABA-producing neurons may help calm the excessive electrical firing of brain cells associated with the disease.

  Email a Link
Use this form to send a link to this article to a friend.

Email this entry to:


Your email address:


Message (optional):


 

For our complete database of ALS news and information go to the ALS NewsCenter

Contact us at email@rideforlife.com  |  Powered by Movable Type  |  Designed by new ajenda  |  Site optimized for 800x600 and above resolutions

This website is a service of Ride for Life, Inc., a 501(c)(3) non-profit organization founded by ALS patients, caregivers, and those concerned about people living with ALS.

Disclaimer: All copyrighted information republished on this website remains the property of the original copyright holder.
Ride for Life, Inc. does not claim to own this information and presents it to our visitors in the spirit of fair usage in order to aid those who are living with ALS.

Privacy Statement: Ride for Life, Inc. does not sell, distribute, or share any personal information.